Ami Bavishi
Investor Relations Contact chez RALLYBIO CORPORATION
Profil
Ami Bavishi is currently the Head of Investor Relations & Corporate Communications at Rallybio Corp.
Prior to this, he worked as the Director of Investor Relations at Aerie Pharmaceuticals, Inc. Mr. Bavishi has a graduate degree from George Washington University and an undergraduate degree from Duquesne University of The Holy Spirit.
Postes actifs de Ami Bavishi
| Sociétés | Poste | Début |
|---|---|---|
| RALLYBIO CORPORATION | Investor Relations Contact | 18/01/2022 |
Anciens postes connus de Ami Bavishi
| Sociétés | Poste | Fin |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Formation de Ami Bavishi
| George Washington University | Graduate Degree |
| Duquesne University of The Holy Spirit | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RALLYBIO CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
